KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 334 filers reported holding KARUNA THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.92 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2023 | $2,833,081 | +84.9% | 8,951 | -1.2% | 0.02% | +61.5% |
Q3 2023 | $1,532,294 | -15.9% | 9,062 | +7.9% | 0.01% | -13.3% |
Q2 2023 | $1,821,106 | +25.9% | 8,398 | +5.4% | 0.02% | +15.4% |
Q1 2023 | $1,446,763 | -2.5% | 7,965 | +5.5% | 0.01% | -7.1% |
Q4 2022 | $1,483,379 | -9.1% | 7,549 | +4.1% | 0.01% | -17.6% |
Q3 2022 | $1,632,000 | +112.8% | 7,255 | +19.7% | 0.02% | +142.9% |
Q2 2022 | $767,000 | +7.9% | 6,059 | +8.1% | 0.01% | +16.7% |
Q1 2022 | $711,000 | -2.5% | 5,605 | +0.7% | 0.01% | 0.0% |
Q4 2021 | $729,000 | +6.1% | 5,568 | -0.9% | 0.01% | 0.0% |
Q3 2021 | $687,000 | +17.2% | 5,617 | +9.3% | 0.01% | +20.0% |
Q2 2021 | $586,000 | +38.9% | 5,141 | +46.4% | 0.01% | +25.0% |
Q1 2021 | $422,000 | +19.5% | 3,512 | +1.1% | 0.00% | +33.3% |
Q4 2020 | $353,000 | +28.8% | 3,473 | -2.1% | 0.00% | 0.0% |
Q3 2020 | $274,000 | -7.1% | 3,548 | +33.9% | 0.00% | -25.0% |
Q2 2020 | $295,000 | – | 2,649 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sofinnova Investments, Inc. | 1,885,602 | $135,763,000 | 12.56% |
PFM Health Sciences, LP | 499,510 | $35,965,000 | 2.95% |
Eventide Asset Management | 901,077 | $64,878,000 | 2.10% |
ACUTA CAPITAL PARTNERS, LLC | 56,000 | $4,032,000 | 1.95% |
Logos Global Management LP | 69,658 | $5,015,000 | 1.91% |
Vivo Capital, LLC | 223,692 | $16,106,000 | 1.46% |
Atika Capital Management LLC | 90,000 | $6,480,000 | 1.24% |
EAM Global Investors LLC | 27,126 | $1,953,000 | 1.14% |
EAM Investors, LLC | 40,516 | $2,917,000 | 0.91% |
MOODY ALDRICH PARTNERS LLC | 25,844 | $1,861,000 | 0.56% |